Arctic Bioscience AS (OSL:ABS) Beta: 0.8886 (As of Jul. 11, 2026)


OSL:ABS Arctic Bioscience AS OSL:ABS
55 GF Score
Price kr3.19
GF Value kr10.62
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arctic Bioscience AS Beta?

Arctic Bioscience AS OSL:ABS -1.85% 55 Beta is 0.8886 as of Jul. 11, 2026. GuruFocus rates OSL:ABS with a GF Score™ of 55/100 and a GF Value™ of kr10.62 (Possible Value Trap). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-11), Arctic Bioscience AS's Beta is 0.8886.


Arctic Bioscience AS  (OSL:ABS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Arctic Bioscience AS Beta Related Terms


Arctic Bioscience AS Beta Historical Data

* Premium members only.

The historical data trend for Arctic Bioscience AS's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arctic Bioscience AS Beta Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 -0.66 -2.38

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.61 -0.66 2.52 -2.38

OSL:ABS vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Arctic Bioscience AS's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arctic Bioscience AS Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arctic Bioscience AS's Beta distribution charts can be found below:

* The bar in red indicates where Arctic Bioscience AS's Beta falls into.


OSL:ABS
55GF Score
Arctic Bioscience AS OSL:ABS
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arctic Bioscience AS Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.8886 mean?
Arctic Bioscience AS (OSL:ABS) has a Beta of 0.8886 as of Jul. 11, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Arctic Bioscience AS and its competitors.
Is Arctic Bioscience AS's Beta too high?
Arctic Bioscience AS's current Beta is 0.8886. Overall, Arctic Bioscience AS has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arctic Bioscience AS's Beta compare to VRTX and REGN?
Arctic Bioscience AS's Beta of 0.8886 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Arctic Bioscience AS and its competitors. Arctic Bioscience AS's current Beta is 0.8886. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arctic Bioscience AS stock overvalued right now?
Based on GuruFocus' analysis, Arctic Bioscience AS (OSL:ABS) is currently considered Possible Value Trap. The stock's GF Value™ is kr10.62, compared to a current price of kr3.19 — trading 70% below its estimated fair value. The current Beta is 0.8886. Arctic Bioscience AS's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Arctic Bioscience AS (OSL:ABS), the current Beta is 0.8886 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arctic Bioscience AS (OSL:ABS) Overvalued in 2026?

Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued. The current stock price of kr3.19 is trading 70% below its estimated GF Value™ of kr10.62. GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.

Key valuation signals for OSL:ABS:

  • Beta: 0.8886
  • GF Value™: kr10.62 vs. price of kr3.19 (70% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the OSL:ABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arctic Bioscience AS Business Description

Other Exchanges 9TD:Germany
Address Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
55GF Score

Get the complete analysis for OSL:ABS

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.19
Price
kr10.62
GF Value